| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |